📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
HGM Reports Q3 Consolidated Loss of ₹3.12 Cr Despite 145% Revenue Growth; Approves $16M RPTs
HandsOn Global Management (HGM) reported a consolidated net loss of ₹312.32 Lakhs for Q3 FY26, a sharp reversal from a profit of ₹132.29 Lakhs in the same quarter last year. This loss occurred despite a robust 145.8% year-on-year surge in consolidated revenue from operations, which reached ₹1,424.54 Lakhs. The bottom line was primarily impacted by a significant spike in employee benefit expenses and other costs. Additionally, the board has sought shareholder approval for material related party transactions totaling approximately US$ 15.95 million with various global entities.
Key Highlights
Consolidated revenue from operations grew 145.8% YoY to ₹1,424.54 Lakhs in Q3 FY26.
Company swung to a consolidated net loss of ₹312.32 Lakhs compared to a profit of ₹132.29 Lakhs in Q3 FY25.
Consolidated EPS declined to -₹2.48 from ₹1.05 in the year-ago quarter.
Board approved material related party transactions (RPTs) totaling US$ 15.95 million, including US$ 8.7M with HealthAxis Group LLC.
Employee benefit expenses on a consolidated basis rose sharply to ₹1,364.88 Lakhs from ₹451.50 Lakhs YoY.
💼 Action for Investors
Investors should exercise caution as the company has turned loss-making at the consolidated level despite strong top-line growth. Closely monitor the upcoming postal ballot regarding the large related party transactions, as these represent a significant portion of the company's scale.
HGM Reports Q3 Consolidated Net Loss of ₹3.12 Cr; Approves $15.95M Related Party Transactions
HandsOn Global Management (HGM) Limited reported a consolidated net loss of ₹312.32 lakhs for the quarter ended December 31, 2025, a significant reversal from a profit of ₹132.29 lakhs in the same period last year. While consolidated revenue grew 145% YoY to ₹1,424.54 lakhs, it declined 24.8% sequentially from Q2. The company also announced major related party transactions totaling approximately $15.95 million with entities including HealthAxis Group and XBP Europe, which require shareholder approval via postal ballot.
Key Highlights
Consolidated revenue from operations rose to ₹1,424.54 lakhs from ₹579.53 lakhs YoY, but fell from ₹1,895.09 lakhs in Q2.
Company swung to a consolidated net loss of ₹312.32 lakhs in Q3 FY26 versus a profit of ₹132.29 lakhs in Q3 FY25.
Employee benefit expenses surged to ₹1,364.88 lakhs from ₹451.50 lakhs in the year-ago quarter.
Board approved material related party transactions totaling $15.95 million (approx. ₹133 Crore) with US and European entities.
Consolidated EPS for the quarter stood at negative ₹2.48 compared to positive ₹1.05 in the previous year.
💼 Action for Investors
Investors should exercise caution as the company has turned loss-making on a consolidated basis despite higher YoY revenues. The substantial volume of proposed related party transactions ($15.95M) relative to current revenue levels requires careful monitoring for corporate governance and operational impact.